News Details
Home / News / Delta Is Surging and Tianlong Is Fighting with You

Delta Is Surging and Tianlong Is Fighting with You

Views:565     Author:Site Editor     Publish Time: 2021-08-21      Origin:Site

Globally, as of 19 August 2021, there were 209,201,939 confirmed cases of COVID-19, including 4,390,467 deaths, reported to WHO. Prevention and control are critical worldwide.


Of these, more than 90% of the new confirmed cases in the UK and India were caused by the Delta variant, the "fastest and fittest" version of the COVID-19 virus. The SARS-CoV-2 Delta variant (B.1.617.2), which was first detected in India, has become the most dominant strain in the world. The Delta variant carries L452R and D614G mutations and is highly contagious and fast-spreading. People infected by the Delta mutant show atypical symptoms as well. The challenge of global epidemic prevention and control is escalating with the surging Delta variant.

To combat the rising cases and deaths caused by the surging Delta variant, the Rapid ACT-Accelerator Delta Response, or RADAR, was launched by the Access to COVID-19 Tools Accelerator, which issued an urgent appeal for $7.7 billion for tests, treatments, and vaccines on 16 August 2021. In the official appeal “RAPID ACT-ACCELERATOR DELTA RESPONSE (RADAR)”, testing ranks the first in the solution proposed by the ACT-Accelerator. Currently and urgently, testing is needed to isolate cases so that transmission is reduced, to ensure treatments are used safely, and to detect whether the Delta variant is mutating further or if new variants are arising.



In response to the changing pandemic globally, Tianlong has always been following up and tracking the mutation information of the SARS-CoV-2 virus and has constantly upgraded the products to fight against COVID-19. Tianlong Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (Fluorescence PCR Method) can detect different variants of SARS-CoV-2, including the vicious Delta variant, with minimized false-negative results.


As an innovative pioneer in the molecular diagnostic industry, Tianlong has demonstrated powerful R&D capabilities, profound technology accumulation, and rich experience in prevention and control. Tianlong devices and extraction reagents for SARS-CoV-2 detection, which have been approved by China NMPA and US FDA, and are CE-certified, have been supplied domestically and globally to arm local professionals in over 50 countries and regions. With the global efforts of all parties, we have faith that the pandemic will end no matter how the mutants emerge in the changing situations.





Get In Touch
No. 389, Zhuhong Road, National Economic and Technological Development Zone, Xi'an City 
© 2021 - Xi'an Tianlong Science and Technology Co., Ltd.